INDIGO Publications Featured Aug 29, 2025 A Novel Carbohydrate Fatty-Acid Monosulphate Ester, Squalane-in-Water Adjuvant Is Safe and Enhances Inactivated Influenza Vaccine Immunogenicity in Older Adults Aug 29, 2025 Aug 29, 2025 Aug 14, 2025 Trust Beyond Borders: European External Regulatory Influence on Access to Medicines Aug 14, 2025 Aug 14, 2025 Jul 31, 2025 Perceptions of respiratory tract infections and their implications for disease prevention practices among older adults in Mysuru, India Jul 31, 2025 Jul 31, 2025 Mar 25, 2025 Pramiti Parwani and Rogier Simons Contribute to "Vaccins" , HighlightING Legal Aspects of Global Vaccine Equity Mar 25, 2025 Mar 25, 2025 Mar 25, 2025 Decoding the Tecfidera Case: The Court of Justice of the European Union’s Verdict on the ‘Same Global Marketing Authorisation’ Mar 25, 2025 Mar 25, 2025 Mar 25, 2025 Beyond Trips and Waivers: The Interactional Law of Intellectual Property Protection and Public Health Mar 25, 2025 Mar 25, 2025 Oct 1, 2024 Breakthrough in Flu Vaccine Research: indigo’s Adjuvant Shows Promise in Humans Oct 1, 2024 Oct 1, 2024 Oct 17, 2023 Carbohydrate fatty acid monosulphate ester is a potent adjuvant for low-dose seasonal influenza vaccines Oct 17, 2023 Oct 17, 2023 Jun 6, 2023 Journal Publication: INDIGO Researchers’ Study on Promising Intradermal Immunization Jun 6, 2023 Jun 6, 2023 Jan 10, 2023 INDIGO Partners Litevax and INSERM publish in Frontiers Journal Jan 10, 2023 Jan 10, 2023
